combo product called Stalevo will allow patients with Parkinson's disease to take fewer tablets
July 2008
A new combo product called Stalevo will allow patients with Parkinson's disease to take fewer tablets.
It contains both standard-release carbidopa/levodopa (Sinemet, etc)...PLUS entacapone (Comtan).
Stalevo will be for patients who already take these drugs separately...or for patients who have "wearing-off" on levodopa. Adding entacapone boosts efficacy of levodopa and helps it last longer.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 300+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive